Global perspectives on the management of primary progressive aphasia.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 08 2024
Historique:
received: 04 03 2024
accepted: 13 08 2024
medline: 26 8 2024
pubmed: 26 8 2024
entrez: 24 8 2024
Statut: epublish

Résumé

Speech-language therapists/pathologists (SLT/Ps) are key professionals in the management and treatment of primary progressive aphasia (PPA), however, there are gaps in education and training within the discipline, with implications for skills, confidence, and clinical decision-making. This survey aimed to explore the areas of need amongst SLT/Ps working with people living with PPA (PwPPA) internationally to upskill the current and future workforce working with progressive communication disorders. One hundred eighty-six SLT/Ps from 27 countries who work with PwPPA participated in an anonymous online survey about their educational and clinical experiences, clinical decision-making, and self-reported areas of need when working with this population. Best practice principles for SLT/Ps working with PwPPA were used to frame the latter two sections of this survey. Only 40.7% of respondents indicated that their university education prepared them for their current work with PwPPA. Competency areas of "knowing people deeply," "practical issues," "connectedness," and "preventing disasters" were identified as the basic areas of priority and need. Respondents identified instructional online courses (92.5%), sample tools and activities for interventions (64.8%), and concrete training on providing care for advanced stages and end of life (58.3%) as central areas of need in their current work. This is the first international survey to comprehensively explore the perspectives of SLT/Ps working with PwPPA. Based on survey outcomes, there is a pressing need to enhance current educational and ongoing training opportunities to better promote the well-being of PwPPA and their families, and to ensure appropriate preparation of the current and future SLT/P workforce.

Identifiants

pubmed: 39181907
doi: 10.1038/s41598-024-70156-5
pii: 10.1038/s41598-024-70156-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19712

Subventions

Organisme : NIA NIH HHS
ID : U24AG074855
Pays : United States
Organisme : National Institute for Health and Care Research
ID : NIHR302240

Informations de copyright

© 2024. The Author(s).

Références

ADI - Dementia statistics. https://www.alzint.org/about/dementia-facts-figures/dementia-statistics/ .
Prince, M., Bryce, R. & Ferri, C. World Alzheimer Report 2011: The benefits of early diagnosis and ... Alzheimer’s Disease International (ADI) (2011). Available at: https://www.alzint.org/u/WorldAlzheimerReport2011.pdf . (Accessed: 7th February 2024)
Prince, M. et al. World Alzheimer Report 2015 - Alzint.org. World Alzheimer Report 2015 (2015). Available at: https://www.alzint.org/u/worldalzheimerreport2015summary.pdf . (Accessed: 7th February 2024)
Zimmerman, R. Dementia as a global public health ‘Tidal wave’. WBUR News (2015). Available at: https://www.wbur.org/news/2015/03/19/dementia-global-public-health-tidal-wave . (Accessed: 7th February 2024)
Koopmans, R. & Rosness, T. Young onset dementia – What does the name imply?. Int. Psychogeriatr. 26, 1931–1933 (2014).
doi: 10.1017/S1041610214001574 pubmed: 25382199
Hendriks, S. et al. Global prevalence of young-onset dementia. JAMA Neurol. 78, 1080–1090 (2021).
doi: 10.1001/jamaneurol.2021.2161 pubmed: 34279544
Hendriks, S. et al. Global incidence of young-onset dementia: A systematic review and meta-analysis. Alzheimer’s Dement. 19, 831–843 (2023).
doi: 10.1002/alz.12695
Vuorinen, E., Laine, M. & Rinne, J. Common pattern of language impairment in vascular dementia and in alzheimer disease. Alzheimer Dis. Assoc. Disord. 14, 81–86 (2000).
doi: 10.1097/00002093-200004000-00005 pubmed: 10850746
Bayles, K. A. & Tomoeda, C. K. Cognitive-Communication Disorders of Dementia: Definition, Diagnosis, and Treatment (Plural Publishing Inc, San Diego, 2015).
Crutch, S. J. et al. Shining a light on posterior cortical atrophy. Alzheimers Dement 9, 463–465 (2013).
doi: 10.1016/j.jalz.2012.11.004 pubmed: 23274153
Klimova, B. & Kuca, K. Speech and language impairments in dementia. J. Appl. Biomed. 14, 97–103 (2016).
doi: 10.1016/j.jab.2016.02.002
Crane, P. K. et al. Incidence of cognitively defined late-onset Alzheimer’s dementia subgroups from a prospective cohort study. Alzheimers Dement 13, 1307–1316 (2017).
doi: 10.1016/j.jalz.2017.04.011 pubmed: 28623677
Mukherjee, S. et al. Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups. Mol. Psychiatry 25, 2942–2951 (2020).
doi: 10.1038/s41380-018-0298-8 pubmed: 30514930
Putcha, D. et al. Word retrieval across the biomarker-confirmed Alzheimer’s disease syndromic spectrum. Neuropsychologia 140, 107391 (2020).
doi: 10.1016/j.neuropsychologia.2020.107391 pubmed: 32057937 pmcid: 7085933
Smith, K. M. & Caplan, D. N. Communication impairment in Parkinson’s disease: Impact of motor and cognitive symptoms on speech and language. Brain Lang. 185, 38–46 (2018).
doi: 10.1016/j.bandl.2018.08.002 pubmed: 30092448
Peterson, K. A., Patterson, K. & Rowe, J. B. Language impairment in progressive supranuclear palsy and corticobasal syndrome. J. Neurol. 268, 796–809 (2021).
doi: 10.1007/s00415-019-09463-1 pubmed: 31321513
Geraudie, A. et al. Speech and language impairments in behavioral variant frontotemporal dementia: A systematic review. Neurosci. Biobehav. Rev. 131, 1076–1095 (2021).
doi: 10.1016/j.neubiorev.2021.10.015 pubmed: 34673112
Duffy, J. R., Utianski, R. L. & Josephs, K. A. Primary progressive apraxia of speech: From recognition to diagnosis and care. Aphasiology 35, 560–591 (2021).
doi: 10.1080/02687038.2020.1787732 pubmed: 34219857
Kimbarow, M. L. & Wallace, S. E. Cognitive Communication Disorders 4th edn. (Plural Publishing, San Diego, 2023).
Gorno-Tempini, M. L. et al. Classification of primary progressive aphasia and its variants. Neurology 76, 1006–1014 (2011).
doi: 10.1212/WNL.0b013e31821103e6 pubmed: 21325651 pmcid: 3059138
Marshall, C. R. et al. Primary progressive aphasia: A clinical approach. J Neurol 265, 1474–1490 (2018).
doi: 10.1007/s00415-018-8762-6 pubmed: 29392464 pmcid: 5990560
Belder, C. R. S. et al. Primary progressive aphasia: Six questions in search of an answer. J. Neurol. 271, 1028–1046 (2024).
doi: 10.1007/s00415-023-12030-4 pubmed: 37906327
Volkmer, A., Spector, A., Warren, J. D. & Beeke, S. Speech and language therapy for primary progressive aphasia: Referral patterns and barriers to service provision across the UK. Dementia (London) 19, 1349–1363 (2020).
doi: 10.1177/1471301218797240 pubmed: 30180763
Taylor-Rubin, C., Croot, K. & Nickels, L. Speech and language therapy in primary progressive aphasia: A critical review of current practice. Expert. Rev. Neurother. 21, 419–430 (2021).
doi: 10.1080/14737175.2021.1897253 pubmed: 33641570
Wauters, L. D. et al. Behavioral treatment for speech and language in primary progressive aphasia and primary progressive apraxia of speech: A systematic review. Neuropsychol. Rev. https://doi.org/10.1007/s11065-023-09607-1 (2023).
doi: 10.1007/s11065-023-09607-1 pubmed: 37792075
Cadório, I., Lousada, M., Martins, P. & Figueiredo, D. Generalization and maintenance of treatment gains in primary progressive aphasia (PPA): A systematic review. Int. J. Lang. Commun. Disord. 52, 543–560 (2017).
doi: 10.1111/1460-6984.12310 pubmed: 28120406
Gallée, J. & Volkmer, A. Role of the speech-language therapist/pathologist in primary progressive Aphasia. Neurol. Clin. Pract. 13, e200178 (2023).
doi: 10.1212/CPJ.0000000000200178 pubmed: 37529299 pmcid: 10389170
Gallée, J. A Roadmap to enhance care for people living with primary progressive Aphasia: What Can Be Done Now?. Perspect ASHA SIGs 8, 847–862 (2023).
doi: 10.1044/2023_PERSP-23-00025
Volkmer, A., Bruns, C., Zimmerer, V., Varley, R. & Beeke, S. Giving voice to people with dementia and their carers: The impact of communication difficulties on everyday conversations. Int. J. Qual. Methods 22, 16094069231171096 (2023).
doi: 10.1177/16094069231171096
Lo, K.-C., Bricker-Katz, G., Ballard, K. & Piguet, O. The affective, behavioural, and cognitive reactions to a diagnosis of Primary Progressive Aphasia: A qualitative descriptive study. Dementia (London) 21, 2476–2498 (2022).
doi: 10.1177/14713012221124315 pubmed: 36054090
Ho, T., Whitworth, A., Hersh, D. & Cartwright, J. “They are dealing with people’s lives…”: Diagnostic and post-diagnostic healthcare experiences in primary progressive aphasia. Int. J. Speech-Lang. Pathol. 25, 449–461 (2023).
doi: 10.1080/17549507.2023.2208311 pubmed: 37212610
Swaffer, K. #Hello, my name is Kate | Dementia Alliance International. Dementia Alliance International https://dementiaallianceinternational.org/about/resources/our-voice-matters/hello-my-name-is-kate (2022).
Volkmer, A. et al. Speech and language therapy approaches to managing primary progressive aphasia. Pract. Neurol. 20, 154–161 (2020).
doi: 10.1136/practneurol-2018-001921 pubmed: 31358572
Volkmer, A., Spector, A., Warren, J. D. & Beeke, S. Speech and language therapy for primary progressive aphasia across the UK: A survey of current practice. Int. J. Lang. Commun. Disord. 54, 914–926 (2019).
doi: 10.1111/1460-6984.12495 pubmed: 31364253
Loizidou, M. et al. ‘Like going into a chocolate shop, blindfolded’: What do people with primary progressive aphasia want from speech and language therapy?. Int. J. Lang. Commun. Disord. 58, 737–755 (2023).
doi: 10.1111/1460-6984.12818 pubmed: 36448629
Ruksenaite, J. et al. Primary progressive aphasia: Toward a pathophysiological synthesis. Curr. Neurol. Neurosci. Rep. 21, 7 (2021).
doi: 10.1007/s11910-021-01097-z pubmed: 33543347 pmcid: 7861583
Furlong, L. & Ttofari Eecen, K. Beyond borders: Innovative ways of thinking and working in speech-language pathology. Int. J. Speech Lang. Pathol. 25, 343–345 (2023).
doi: 10.1080/17549507.2023.2224195 pubmed: 37480227
Volkmer, A. et al. Principles and philosophies for speech and language therapists working with people with primary progressive aphasia: an international expert consensus. Disabil. Rehabil. 45, 1063–1078 (2023).
doi: 10.1080/09638288.2022.2051080 pubmed: 35352609
Savage, S. A., Suárez-González, A., Cassani, A., Gopalan, R. & Stott, J. Non-primary progressive language impairment in neurodegenerative conditions: protocol for a scoping review. Syst. Rev. 10, 32 (2021).
doi: 10.1186/s13643-021-01589-6 pubmed: 33472694 pmcid: 7816313
Suárez-González, A., Cassani, A., Gopalan, R., Stott, J. & Savage, S. When it is not primary progressive aphasia: A scoping review of spoken language impairment in other neurodegenerative dementias. Alzheimers Dement 7, 12205 (2021).
Volkmer, A. et al. ‘Communication is difficult’: Speech, language, and communication needs of people with young onset or rarer forms of non-language led dementia. Int. J. Lang. Commun. Disord 59(4), 1553–1577 (2024).
doi: 10.1111/1460-6984.13018 pubmed: 38329409
Fried-Oken, M., Mooney, A. & Peters, B. Supporting communication for patients with neurodegenerative disease. NeuroRehabilitation 37, 69–87 (2015).
doi: 10.3233/NRE-151241 pubmed: 26409694 pmcid: 6380499
Rowe, H. P., Shellikeri, S., Yunusova, Y., Chenausky, K. V. & Green, J. R. Quantifying articulatory impairments in neurodegenerative motor diseases: A scoping review and meta-analysis of interpretable acoustic features. Int. J. Speech Lang Pathol. 25, 486–499 (2023).
doi: 10.1080/17549507.2022.2089234 pubmed: 36001500
Eysenbach, G. Improving the quality of Web surveys: the checklist for reporting results of internet E-surveys (CHERRIES). J. Med. Internet Res. 6, e34 (2004).
doi: 10.2196/jmir.6.3.e34 pubmed: 15471760 pmcid: 1550605
The International Speech and Language Therapy / Pathology Primary Progressive Aphasia Network. https://speechtherapyppa.builtbyknights.com/ .
World Population Prospects - Population Division - United Nations. https://population.un.org/wpp/DefinitionOfRegions/ .
Hardy, C. J. D. et al. Symptom-led staging for semantic and non-fluent/agrammatic variants of primary progressive aphasia. Alzheimers Dement 20, 195–210 (2024).
doi: 10.1002/alz.13415 pubmed: 37548125
Lo, K.-C., Bricker-Katz, G., Ballard, K. & Piguet, O. The affective, behavioural, and cognitive reactions to a diagnosis of Primary Progressive Aphasia: A qualitative descriptive study.
World Bank Open Data. World Bank Open Data https://data.worldbank.org . (Accessed: 7th February, 2024)

Auteurs

Jeanne Gallée (J)

Center for Psychometric Analyses of Aging and Neurodegeneration, Department of Medicine, University of Washington, Seattle, WA, USA. jgallee@uw.edu.
Department of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA, USA. jgallee@uw.edu.
School of Health Sciences, University of Tasmania, Launceston, Australia. jgallee@uw.edu.

Jade Cartwright (J)

School of Health Sciences, University of Tasmania, Launceston, Australia.

Stephanie Grasso (S)

Department of Speech, Language, and Hearing Sciences, The University of Texas at Austin, Austin, TX, USA.

Regina Jokel (R)

Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
Rotman Research Institute, Toronto, Canada.

Monica Lavoie (M)

The Chaire de recherche sur les aphasies primaires progressives - Fondation de la famille Lemaire, Université Laval, Quebec, Qc, Canada.
Clinique Interdisciplinaire de Mémoire, CHU de Québec-Université Laval, Quebec, QC, Canada.

Ellen McGowan (E)

Pennine Care NHS Foundation Trust, Greater Manchester, Derbyshire, UK.

Margaret Pozzebon (M)

Age Right Speech Pathology, Melbourne, Australia.

Bárbara Costa Beber (BC)

Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.

Guillaume Duboisdindien (G)

The Chaire de recherche sur les aphasies primaires progressives - Fondation de la famille Lemaire, Université Laval, Quebec, Qc, Canada.
Clinique Interdisciplinaire de Mémoire, CHU de Québec-Université Laval, Quebec, QC, Canada.

Núria Montagut (N)

Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Barcelona, Spain.
Institut d'Investigació Biomèdica August Pi I Sunyer, Barcelona, Spain.

Monica Norvik (M)

Department of Education, UiT The Arctic University of Norway, Tromsø, Norway.

Taiki Sugimoto (T)

Center for Psychometric Analyses of Aging and Neurodegeneration, Department of Medicine, University of Washington, Seattle, WA, USA.
Department of Prevention and Care Science, National Center for Geriatrics and Gerontology, Research Institute, Obu, Japan.

Rosemary Townsend (R)

Dyscover Ltd, Leatherhead, UK.

Nina Unger (N)

Department of Neurology, University Medicine Greifswald, Greifswald, Germany.

Ingvild E Winsnes (IE)

Department of Linguistics and Scandinavian Studies, University of Oslo, Oslo, Norway.

Anna Volkmer (A)

Department of Psychology and Language Science, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH